Optum Ventures’ investment of $7.5 million pushed Waltham, Massachusetts-based SHYFT over its funding goal. The startup did not specify what its Series B funding round goal was, but it did state the round was oversubscribed.

Other investors included health care giant McKesson and Medidata, a cloud analytics company.

Founded in 2006, SHYFT uses clinical and commercial data to help life science companies develop products and improve commercialization activities. By investing $7.5 million in the company, Optum Ventures will join SHYFT’s board of directors.

“Our growth is a reflection of the value we’re delivering to our customers and the importance of data analytics in clinical and commercial decision making,” said Zack King, CEO of SHYFT. “The investment from Optum is an affirmation of that value and of our shared view of the exciting and transformative changes happening in health care today.”

SHYFT said the funding would fuel an expansion as it develops cloud-based analytic software for use in the fields of real world evidence medicine, specialty pharmaceuticals, and rare disease.

Current Issue

Most Popular

Who We Are

Twin Cities Business is Minnesota’s leading provider of business news, insight, and analysis through daily online news stories, e-newsletters, a monthly print magazine and live events. Along with our readers, we get to know the personalities of our region’s most influential leaders, exploring the “how” behind their success, strategies, and solutions. We discuss today’s most pressing issues, examine trends and outlooks, and provide the context, perspective, and information leaders have come to depend upon.